Tidal Investments’s Corcept Therapeutics CORT Stock Holding History

Tidal Investments’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.11M	Buy	24,218 +2,039	+9%	+$123K	﹤0.01%	1336
2026 Q1	$894K	Buy	22,179 +9,684	+78%	+$362K	﹤0.01%	1534
2025 Q4	$435K	Sell	12,495 -1,000	-7%	-$78.5K	﹤0.01%	1713
2025 Q3	$1.12M	Sell	13,495 -10	-0.1%	-$724	﹤0.01%	1160
2025 Q2	$991K	Buy	13,505 +3,470	+35%	+$252K	0.01%	1043
2025 Q1	$1.15M	Buy	+10,035	New	+$611K	0.01%	922
2023 Q2	–	Sell	-56,111	Closed	-$1.22M	–	1319
2023 Q1	$1.22M	Sell	56,111 -10,184	-15%	-$223K	0.04%	426
2022 Q4	$1.35M	Buy	+66,295	New	+$1.66M	0.05%	359

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tidal Investments's CORT Position: Q2 2026 in Review

Tidal Investments increased its Corcept Therapeutics (CORT) stake by 9.2% in Q2 2026, buying an estimated $123K and bringing the position to 24,218 shares worth $2.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1336.

Tidal Investments first reported a position in CORT in Q4 2022 and has held it in 8 quarters since. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Tidal Investments held 24,218 shares of Corcept Therapeutics worth $2.11M as of Q2 2026.
Tidal Investments bought 2,039 Corcept Therapeutics shares in Q2 2026, an estimated $123K.
Corcept Therapeutics made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1336 holding.
Tidal Investments first reported a position in Corcept Therapeutics in Q4 2022 and has held it in 8 quarters since.
423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.